Similar Posts

True Stories of the Challenges of Neurological Conditions and Bladder and Bowel Programs – Laurie’s Story
Laurie’s Story December 14, 2005, started out like every other workday. I needed to get dressed, but decided to fix my coffee first and that is when I realized something was different. I was stirring my coffee and both my feet began to tingle as if they were asleep. I tried stomping my feet on…

Dignify Therapeutics Announces the Issuance of US Patent No. 10,086,034 for treatment of voiding dysfunction
RESEARCH TRIANGLE PARK, NC (RTP) – October 18, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announces the issuance of US Patent No. 10,086,034, which relates to pharmacological methods of inducing urination and defecation. Dr. Karl Thor, Chief Scientific Officer and patent co-inventor stated “This is an important…
Dignify Therapeutics Highlights Clinical Development Plans at the BIO CEO & Investor Conference
Research Triangle Park, NC – February 14, 2025 – Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development plans for its lead assets, DTI-117 and DTI-301, at the BIO CEO & Investor Conference held in New York on February 10-11, 2025. During…
Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
Company RESEARCH TRIANGLE PARK, NC (October 22, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program ‘geared towards healthcare companies with a product ready to launch into…
Dignify Therapeutics awarded two new research grants from the National Institutes of Health (NIH)
RESEARCH TRIANGLE PARK, NC (September 19, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two significant research grants from the NIH. These grants add to the previous $20 million in research funding the company has received to advance multiple therapeutics for bladder and bowel disorders. Grants…

Restoring Voluntary Bladder & Bowel Control for the Spinal Cord Injured – How You Can Help
About Current Bladder and Bowel Programs Thank you for your interest in Dignify Therapeutics’ journey to restore voluntary control of bodily functions to people with spinal cord conditions such as paraplegia, spina bifida, and multiple sclerosis. For many with these conditions, restoring control over their bladder and bowel is just as important as gaining mobility. The current…